|
Delayed
OTC Markets
10:29:58 2026-09-14 am EDT
|
5-day change | 1st Jan Change | ||
| 14.80 USD | +1.65% |
|
+0.75% | +11.36% |
| Sep. 01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| Sep. 01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
| Market Cap | 4,110B 26.76B 23.06B 21.83B 19.79B 37.13B 2,557B 37.32B 259B 99.72B 1,301B 101B 98.31B | P/E 2027 * |
10.7x | P/E 2028 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4,051B 26.38B 22.73B 21.52B 19.51B 36.59B 2,520B 36.78B 256B 98.29B 1,282B 99.07B 96.89B | EV / Sales 2027 * |
1.73x | EV / Sales 2028 * | 1.67x |
| Free-Float |
98.88% | Yield 2027 * |
3.58% | Yield 2028 * | 3.71% |
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| ALPMY | Delayed | |
Deutsche Boerse AG
| YPHA | Delayed |
Last Transcript: Astellas Pharma Inc.
| 1 day | +1.65% | ||
| 1 week | +0.75% | ||
| Current month | +0.14% | ||
| 1 month | +0.54% | ||
| 3 months | +10.61% | ||
| 6 months | -0.54% | ||
| Current year | +11.36% |
| 1 week | 13.92 |  | 15.42 |
| 1 month | 13.92 | | 16.01 |
| Current year | 12.82 | | 17.35 |
| 1 year | 10.03 | | 17.35 |
| 3 years | 8.37 | | 17.35 |
| 5 years | 8.37 | | 18.18 |
| 10 years | 8.37 | | 18.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 64 | 2023-02-09 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 2023-10-31 |
Tatjana Dragovic
CMP | Compliance Officer | - | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 2023-02-09 |
Naoki Okamura
BRD | Director/Board Member | 64 | 2019-05-31 |
| Director/Board Member | 59 | 2023-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.65% | +0.75% | - | - | 26.16B | |
| +2.19% | +1.49% | +52.45% | +92.80% | 994B | |
| +1.19% | +0.04% | +51.76% | +64.43% | 640B | |
| +1.27% | +4.84% | +19.86% | +69.76% | 454B | |
| +4.94% | +1.67% | +38.06% | +38.51% | 337B | |
| +1.95% | -9.02% | +16.87% | +25.11% | 261B | |
| +3.18% | +0.12% | +5.62% | +11.49% | 246B | |
| +0.21% | -3.90% | +37.69% | +44.04% | 204B | |
| +1.41% | -6.39% | -21.19% | -59.02% | 190B | |
| +0.92% | -0.88% | +29.16% | +87.89% | 178B | |
| Average | +1.87% | -5.76% | +25.59% | +41.67% | 389.42B | |
| Weighted average by Cap. | +1.98% | -4.42% | +34.75% | +57.36% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,338B 15.22B 13.12B 12.42B 11.26B 21.12B 1,454B 21.23B 148B 56.72B 740B 57.17B 55.92B | 2,180B 14.19B 12.23B 11.58B 10.5B 19.69B 1,356B 19.79B 138B 52.89B 690B 53.31B 52.14B |
| Net income | 361B 2.35B 2.03B 1.92B 1.74B 3.26B 225B 3.28B 22.78B 8.76B 114B 8.83B 8.64B | 340B 2.21B 1.91B 1.8B 1.64B 3.07B 211B 3.08B 21.43B 8.24B 108B 8.31B 8.12B |
| Net Debt | -59.18B -385M -332M -314M -285M -535M -36.81B -537M -3.73B -1.44B -18.73B -1.45B -1.42B | -481B -3.13B -2.7B -2.55B -2.31B -4.34B -299B -4.36B -30.32B -11.66B -152B -11.75B -11.5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-14 | $14.80 | +1.65% | 21,988 |
| 26-09-11 | $14.56 | +2.39% | 87,645 |
| 26-09-10 | $14.22 | -1.46% | 138,038 |
| 26-09-09 | $14.43 | -1.77% | 214,328 |
| 26-09-08 | $14.69 | -2.39% | 100,627 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
Select your edition
All financial news and data tailored to specific country editions
